Heron Therapeuti
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +93.5% | +184.0% | +134.3% | +0.7% | +17.3% | +15.1% | +49.4% | +14.5% | +45.8% | +9.6% | +16.0% | +16.3% | -17.7% | -27.6% | -10.8% | -11.9% | +3.2% | -2.8% | +12.1% | +3.5% | -11.1% | +13.6% | +17.8% | -3.9% | +13.1% | -1.4% | +7.2% | -1.0% | +8.9% | +1.3% | +3.9% | -8.9% | +24.3% | -4.6% | -4.4% | +2.7% | +6.2% | -14.5% | +8.5% | – | |
| – | -99.9% | +3,288.6% | -14.6% | +3.8% | +27.3% | +134.2% | +67.0% | +44.8% | +52.7% | +29.3% | -9.2% | +26.5% | -7.7% | -33.1% | -15.2% | -20.4% | +31.0% | -2.0% | +57.7% | -21.8% | -3.6% | +3.8% | +42.4% | -9.0% | -14.2% | +33.5% | +19.6% | -9.7% | -45.7% | -14.6% | +24.6% | -10.1% | +8.1% | -17.3% | +16.6% | +56.1% | -50.3% | +39.1% | +8.8% | – | |
| – | – | +96.6% | +206.5% | +0.3% | +15.9% | -3.2% | +42.8% | +1.4% | +41.5% | -3.7% | +38.6% | +10.2% | -24.5% | -23.1% | -7.5% | -6.4% | -12.4% | -3.6% | -26.7% | +50.0% | -18.2% | +24.6% | -5.3% | +3.4% | +47.0% | -26.7% | -9.1% | +14.0% | +84.1% | +7.7% | -2.7% | -8.4% | +30.8% | -0.4% | -10.2% | -16.5% | +44.3% | -26.9% | +8.4% | – | |
| – | -2.4% | +13.1% | -14.3% | +0.9% | +65.6% | -17.2% | -23.8% | +0.9% | +31.1% | +7.7% | -3.6% | -16.2% | +39.1% | -23.6% | +19.3% | +11.8% | -9.6% | -14.3% | -7.6% | -18.8% | +1.0% | +45.7% | -31.5% | -11.4% | -56.7% | -20.1% | +49.5% | +2.6% | -19.2% | -57.9% | -3.8% | +0.7% | -28.8% | -28.3% | +28.7% | +18.3% | +8.0% | -36.3% | +13.3% | – | |
| – | +10.5% | +14.4% | -8.3% | +4.5% | -4.6% | +14.0% | -11.7% | +17.4% | +19.9% | +10.4% | +1.3% | -12.1% | +14.9% | +5.5% | -5.8% | -3.4% | +31.9% | -23.4% | +13.9% | -10.3% | +1.0% | -3.6% | -3.7% | +6.7% | -8.9% | +77.4% | +23.7% | -40.6% | -3.0% | +32.6% | -7.1% | -11.0% | -1.8% | +4.6% | +13.9% | -3.4% | -3.8% | -9.7% | -7.2% | – | |
| – | +0.7% | +7.7% | -4.2% | -1.4% | +44.6% | -14.4% | -15.8% | +6.1% | +27.0% | +18.6% | -8.0% | -19.5% | +30.3% | -14.1% | +2.8% | +2.5% | +1.9% | -13.2% | +8.7% | -7.0% | -0.5% | +18.6% | -18.8% | -11.9% | -29.7% | +21.4% | +17.9% | -29.4% | -9.4% | -10.3% | +3.0% | -13.0% | -5.1% | +3.5% | +6.2% | -7.1% | +22.2% | -12.3% | -2.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -24.4% | -151.9% | – | – | -12,639.5% | – | – | |
| – | +281.5% | -65.2% | -27.8% | -25.8% | +191.8% | -50.3% | +0.0% | -37.5% | +434.4% | -88.8% | +33.3% | +0.0% | +268.0% | – | – | – | – | – | – | – | – | -60.0% | +611.0% | -99.6% | +9,415.4% | -88.1% | +90.8% | +0.0% | +285.1% | -74.0% | -29.0% | +25.0% | +786.4% | -88.7% | +0.0% | +480.0% | -65.5% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -28.1% | -190.4% | – | – | – | – | – | |
| – | – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +611.0% | -99.6% | +28,130.8% | -104.0% | – | +24.3% | -61.5% | +118.9% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -28.1% | -190.4% | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -57.8% | -148.0% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.